article
Informatics In-Depth Focus 2015
In this Informatics In-Depth Focus: Informatics in 2025, Methods for the detection of drug-drug interactions in text & Computational approaches to mutagenicity assessments of impurities: in silico methods...
List view / Grid view
GlaxoSmithKline (GSK)
article
Foreword: The importance of good distribution practice
Historically, the regulation and control of medicinal products has relied on national and supranational guidelines covering good manufacturing practice (GMP). However, the quality of these medicinal products can be adversely affected by a lack of adequate control over the myriad activities that occur during the distribution process. In addition, the…
article
Drugs shortages are finally being addressed
Maintaining the security of the supply chain for drug products is a significant responsibility to ensure the sustained availability of safe medicines...
article
LC-MS In-Depth Focus 2015
In this free-to-view LC-MS in-depth focus, we delve into the world of glycans, and how their natural complexity necessitates sophisticated sequencing techniques, while another article aims to demonstrate the versatility of LC-MS and the ease with which it can be combined with a variety of MS systems, focusing particularly on…
article
The cost of drug counterfeiting
The World Health Organisation (WHO) in 2010 described counterfeit medicines as those which are “Deliberately and fraudulently mislabelled with respect to identity and/or source. Counterfeiting can apply to both branded and generic products and counterfeit products may include products with the correct ingredients or with the wrong ingredients, without active…
news
GlaxoSmithKline encounters initial resistance following directional shift, says GlobalData Analyst
11 February 2015 | By GlobalData
Following a less than flattering financial performance in 2014, GlaxoSmithKline plc is realigning its operating structure with its corporate objectives and cashing in on its assets in the process, as the company seeks to drive up external investments and deliver stronger shareholder returns in the long term, says an analyst…
news
Major milestone for GSK/NIH candidate Ebola vaccine as first doses shipped to Liberia for use in phase III clinical trial
23 January 2015 | By GlaxoSmithKline
GSK has announced that the first batch of its candidate Ebola vaccine is being shipped to west Africa...
article
Screening: In-Depth Focus 2014
This free-to-view Screening In-Depth Focus is packed with articles that will give you a greater understanding of interesting topics such as the identification of compounds that protect against free radicals, advancements in sandwich immunoassay techniques and hit validation and optimisation...
article
Cocrystals: defining the opportunity
Cocrystals can help to address the manufacturability (flow, compaction, processability) as well as solubility/dissolution,hygroscopicity and stability properties of an active pharmaceutical ingredient (API).
news
GSK presents asthma data that shows no additional clinical efficacy benefits for ICS-treatments with a small particle size
9 December 2014 | By GSK
GSK presented data at the British Thoracic Society meeting from a systematic analysis of 25 randomised control studies (RCTs), including a meta-analysis of three key efficacy outcomes, which explored the potential impact of the particle size of different ICS-containing asthma medicines, including Seretide/Advair (salmeterol/fluticasone proprionate) on patient outcomes...
news
Medidata collaborates with GlaxoSmithKline on mobile health initiative to test novel technology for clinical trial optimization
17 November 2014 | By Medidata
Joint initiative evaluates impact of mHealth and cloud-based technologies on patient engagement, data quality and operational efficiencies in clinical trials...
news
GSK launches first call for proposals for research in to non-communicable diseases in Sub-Saharan Africa
14 November 2014 | By GlaxoSmithKline
GSK launched the first call for proposals for its Africa NCD Open Lab, to support much-needed scientific research into non-communicable diseases (NCDs) in Africa...
article
Crystallography: A Core Science?
Crystallography is the science underpinning crystallisation, as well as a basic understanding of atomic arrangement within solids and their resulting structures. The United Nations announced that 2014 would be the International Year of Crystallography (IYCr2014). IYCr2014 commemorates the 100th anniversary of X-ray diffraction according to Bragg’s Law (celebrated by the…
news
Results announcement for the third quarter 2014
24 October 2014 | By GlaxoSmithKline
GSK announces Q3 core EPS of 27.9p +5% CER excluding divestments and dividend of 19 pence per share...
news
GSK appoints Mr Urs Rohner to its Board as a Non-Executive Director
6 October 2014 | By GlaxoSmithKline
GlaxoSmithKline plc announced the appointment of Mr Urs Rohner to its Board as a Non-Executive Director, effective 1 January 2015...
